Accord Healthcare is delighted to announce the launch of another Hi-Tech medicine to their already extensive range of Hi Tech medicines, Ambrisentan Accord 5 & 10 mg which come in pack sizes of 30 Film-Coated Tablets .
This medicine is indicated for treatment of pulmonary arterial hypertension (PAH) in adult patients of WHO Functional Class (FC) II to III. Efficacy has been shown in idiopathic PAH (IPAH) and in PAH associated with connective tissue disease.
For verified healthcare professionals
Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.